ACP Cautions Against COVID-19 Vaccine Recommendation Changes
American College of Physicians leaders warn that abrupt changes to COVID-19 vaccine recommendations could jeopardize payment coverage and place millions of Americans at risk.
Category: US Pharmaceuticals
US Pharmaceuticals
Latest
ACP Cautions Against COVID-19 Vaccine Recommendation Changes
American College of Physicians leaders warn that abrupt changes to COVID-19 vaccine recommendations could jeopardize payment coverage and place millions of Americans at risk.
Read More
FDA Approves Mepolizumab for Adults with COPD
The US FDA has approved mepolizumab (Nucala) as an add-on maintenance treatment for adult patients with inadequately controlled COPD and an eosinophilic phenotype.
Read More
Split Decision as COPD Drug Itepekimab Fails One Clinical Trial
Sanofi and Regeneron’s COPD drug candidate itepekimab met its primary endpoint in one phase 3 study but failed in a second trial.
Read More
Moderna Withdraws FDA Application for Combo Flu-COVID Vaccine
Moderna’s biologics license application for its flu/COVID combination vaccine candidate for adults aged 50 years and older.
Read More
Tezepelumab Reduced, Eliminated OCS Use in Severe Asthma Patients
Treatment with tezepelumab (Tezspire) can substantially reduce or eliminate oral corticosteroid (OCS) use in adults with OCS-dependent severe asthma, according to new Phase 3 WAYFINDER results presented at ATS 2025.
Read More
Studies Suggest Peptide May Benefit Idiopathic Pulmonary Fibrosis Patients
Two posters presented at ATS 2025 offered data on Rein Therapeutics’ novel peptide LTI-03’s potential clinical value for idiopathic pulmonary fibrosis patients.
Read More
Albuterol–Budesonide vs Albuterol-only for Asthma Exacerbations
Results from the BATURA Phase IIIb trial found that albuterol–budesonide (AirSupra) demonstrated a 47% reduction in the risk of severe exacerbations in mild asthma compared with albuterol alone
Read More
Simplifying Medication Delivery with Multi-drug Capsules
Engineers are testing a capsule that can be packed with multiple medications and release them at designated times throughout the day.
Read More
President Trump’s Executive Order Targets Prescription Drug Costs
President Trump signed an executive order on Monday to “bring the prices Americans and taxpayers pay for prescription drugs in line with those paid by similar nations,” according to a White House news release.
Read More
COVID-19 Vaccines Not Linked to Miscarriage
There is no association between the COVID-19 vaccine and miscarriage, a new Obstetrics and Gynecology study confirms.
Read More
Asthma Therapy Breztri Shows Lung Function Improvements in Phase III Trials
Two Phase III trials in patients with uncontrolled asthma found Breztri Aerosphere met all primary endpoints, demonstrating a statistically significant and clinically meaningful improvement in lung function.
Read More
After Flovent Pulled, Asthmatic Kids Quit Inhalers
Study suggests the 2024 withdrawal of the asthma medication Flovent was linked to increases in children discontinuing inhaled steroid therapy.
Read More
Bronchiectasis: Brensocatib Reduced Exacerbations, Slowed Lung Function Decline
Brensocatib significantly reduced the rate of pulmonary exacerbations in patients with non-cystic fibrosis bronchiectasis compared to placebo.
Read More
Federal Agency to Cease Collection of Adverse Drug Reports
The Consumer Product Safety Commission will stop collecting data on injuries from adverse drug effects and other incidents like car accidents, according to a report from Reuters.
Read More
Frequent Pediatric Antibiotics May Increase Asthma, Allergy Risks
Repeated antibiotic use before age 2 is associated with a higher risk for asthma, food allergies and hay fever later in life.
Read More
National Investment in COVID-19 Vaccine Had Positive ROI
The United States prevented far more in medical spending and lost-productivity than it spent on testing, buying and delivering the COVID-19 vaccines.
Read More
Novel COVID Antiviral May Overcome Paxlovid Limitations
In laboratory testing, new drug candidate Jun13296 remained effective against Paxlovid-resistant strains of the coronavirus SARS-CoV-2.
Read More
Low-sugar Vaccine Provides Broad Immunity Against Coronavirus Variants
Researchers have developed a universal vaccine that targets coronaviruses and the sugars that they use as cover.
Read More
Current Antivirals Less Effective Against Severe Bird Flu
Two FDA–approved flu antivirals did not successfully treat severe H5N1 infections, and route of infection (eye, nose or mouth) significantly impacted effectiveness.
Read More
FDA Issues Recommendations for Flu Vaccine Composition
The FDA convened an interagency panel to comprise its recommendations for the 2025-2026 flu vaccine composition.
Read More
FDA Approves Biosimilar Omlyclo for Asthma
Omlyclo (omalizumab-igec) is the first and only biosimilar designated as interchangeable with Xolair (omalizumab) for the treatment of moderate to severe persistent asthma, CRSwNP, IgE-mediated food allergy, and chronic spontaneous urticaria.
Read More
Tezspire Significantly Reduced Nasal Congestion, Polyp Size in CRwNP Patients
Tezspire, an add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma, showed significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in a Phase 3 clinical trial.
Read More
Study Compares Xolair to Oral Immunotherapy in Treating Food Allergies
Xolair was superior to oral immunotherapy in both effectiveness and fewer side effects for people with one or more food allergies.
Read More
FDA, CDC Cancel Flu Vaccine Advisory Meetings
A scheduled meeting of the US FDA’s influenza vaccine advisory board set for March 13 has been canceled, following another postponement by the CDC last week.
Read More